Loading

Legalization

  • by Keith Stroup, NORML Legal Counsel September 24, 2016

    C1_8734_r_xThose of us involved in the marijuana legalization movement have long assumed that those companies that produce and sell competing products — especially alcohol and tobacco — were working behind the scenes to try to maintain marijuana prohibition and to protect their duopoly for legal recreational drugs. These industries have lobbyists who regularly work with state and federal elected officials to keep legal marijuana off the market.

    But we now see the pharmaceutical companies are also getting directly involved in political efforts to maintain marijuana prohibition, worried that legal marijuana will undermine their bottom line.

    Pharmaceutical company joins the war on marijuana smokers.

    Recently, we saw the first direct evidence that pharmaceutical companies are now working to defeat marijuana legalization efforts, acknowledging that their intent is to protect their market in synthetic opioid drugs.

    Earlier this month, Insys Therapeutics Inc., an Arizona-based company, donated $500,000 to a group calling itself Arizonans for Responsible Drug Policy, a newly formed organization established to try to defeat Proposition 205, the marijuana legalization voter initiative that will appear on the ballot this November in that state.

    Insys currently markets just one product, Subsys, a sublingual fentanyl spray, a synthetic opioid far more potent than heroin (fentanyl is the drug found in Prince’s system following his death in April). “Insys Therapeutics made $62 million in net revenue on Subsys fentanyl sales in the first quarter of this year, representing 100 percent of the company’s earnings,” according to The Washington Post. “The CDC has implicated the drug in a ‘surge’ of overdose deaths in several states in recent years.”

    Survey data compiled from medical marijuana patients show that subjects often reduce their use of prescription drug therapies — particularly opioids — when they have legal access to cannabis. According to a 2015 RAND Corp. study, opiate-related abuse and mortality is lower in jurisdictions that permit medical cannabis access, compared to those that outlaw the plant.

    Insys has come under scrutiny of law enforcement. According to The Washington Post, a number of states are currently investigating Insys for illegally paying physicians to prescribe their drug in situations in which it was inappropriate. Illinois Attorney General Lisa Madigan filed a lawsuit against the company, claiming the company’s “desire for increased profits led it to disregard patients’ health and pushed addictive opioids for non-FDA approved purposes.”

    The smoking gun.

    When the company first made its half-million dollar contribution to the group opposing the Arizona legalization initiative — the largest single contribution to the group by a factor of four — the company claimed that its reason for opposing the voter initiative was “because it fails to protect the safety of Arizona’s citizens and particularly its children.”

    But when the company filed a legally required disclosure statement with the Securities and Exchange Commission, it acknowledged to shareholders that it was making the donation because it feared a decline in the sales of its powerful opioid product and that of a second drug it is developing: Dranabinol, a synthetic cannabinoid. Synthetic cannibinoid is a blanket term for an artificial version of tetrahydrocannabinol, or THC — the active compound in the marijuana plant — intended to alleviate chemotherapy-caused nausea and vomiting. The company concedes that the scientific literature has confirmed the benefits of natural marijuana over synthetic THC:

    “Legalization of marijuana or non-synthetic cannabinoids in the United States could significantly limit the commercial success of any dronabinol product candidate. … If marijuana or non-synthetic cannabinoids were legalized in the United States, the market for dronabinol product sales would likely be significantly reduced, and our ability to generate revenue and our business prospects would be materially adversely affected.”

    The Arizona Republic reported that the company, while publicly claiming to have kids’ best interests in mind, is clearly more concerned with ways to “protect its own bottom line.”

    And the company has good reason for that fear. Recently published studies have found that states that provide for the legal use of medical marijuana had a 25 percent decline in opioid prescriptions. Another recent study from Columbia University found the implementation of medical marijuana programs is associated with a decrease in the prevalence of opioids detected among fatally injured drivers, based on a review of 69,000 fatalities in 18 states, according to data published in the American Journal of Public Health. Where legal marijuana is available, people use far fewer opioid drugs.

    So we now have direct evidence that this pharmaceutical company in Arizona is spending large amounts of money to avoid having to compete with legal marijuana, in order to protect its market share for an addictive and dangerous synthetic opioid and a synthetic form of THC, at the expense of public health.

    This is not the first instance of pharmaceutical companies pouring money into the “war on drugs.” In 2014, The Nation published an article revealing that the makers of Oxycontin and Vicodin were two of the largest contributors to The Partnership for Drug Free Kids and the Community Anti-Drug Coalition of America, two groups that oppose marijuana legalization and support continued prohibition.

    Insys will certainly not be the last pharmaceutical company caught putting company profits ahead of concern for public health, but it is the first instance we have seen where a company was caught with its hands in the cookie jar, opposing a marijuana legalization initiative purely for reasons of corporate greed.

    Tobacco and alcohol companies have long opposed legal marijuana.

    It is understandable that recreational and pharmaceutical industries would not wish to compete with legal marijuana. By any measure, their products are far more dangerous and far more addictive.

    Overdose Deaths.

    For comparison purposes, according to the National Institute on Alcohol Abuse and Alcoholism, excessive alcohol use results in approximately 88,000 deaths per year in this country. And, according to the Centers for Disease Control and Prevention, tobacco smoking results in more than 480,000 deaths each year in this country, about 1,300 people each day.

    A 2014 study by Johns Hopkins University found that states that legalized medical marijuana saw a 25 percent decline in overdose deaths from prescription drugs.

    Marijuana has never caused an overdose death in the history of mankind. According to a recent report from the World Health Organization, one would have to smoke “between 238 and 1,113 joints a day – or at least 10 joints an hour, for 24 hours straight – before overdose would become a realistic concern” for marijuana.

    Addictive potential.

    While one can develop a dependence on marijuana smoking, the threat of dependence with marijuana is far less than with either alcohol or tobacco. Here is what the National Academy of Sciences Institute of Medicine concluded in regard to cannabis’ potential dependence liability, in the context of other controlled substances:

    “In summary, although few marijuana users develop dependence, some do. But they appear to be less likely to do so than users of other drugs (including alcohol and nicotine), and marijuana drug dependence appears to be less severe than dependence on other drugs.”

    Here are their dependence ratings:

    Tobacco: 32 percent (proportion of users who ever become dependent)
    Heroin: 23 percent
    Cocaine: 17 percent
    Alcohol: 15 percent
    Anxiolytics/sedatives: 9 percent
    Marijuana/hashish: 9 percent

    So if one is electing to use a recreational drug, marijuana is clearly the safest alternative. And if one is using an opioid drug for pain, they should experiment with marijuana as a substitute for the more dangerous and addictive opioids. For many, it is an effective and far less dangerous alternative.

    _____________________________________________________________________

    Keith Stroup is a Washington, D.C. public-interest attorney who founded NORML in 1970.

    This column was first published in ATTN.com.

    http://www.attn.com/stories/11586/pharmaceutical-company-admits-opposing-marijuana-legalization

     

  • by Danielle Keane, NORML Political Director September 23, 2016

    thumbs_upNext Tuesday is National Voter Registration Day and NORML will be releasing an updated and revised 2016 Congressional Scorecard. The Scorecard is an all-encompassing database that assigns a letter grade ‘A’ through ‘F’ to members of Congress based on their marijuana-related comments and voting records.

    With the 2016 presidential election drawing closer and statewide marijuana initiatives qualified for the ballot in nine states, we need YOU to make it out to the polls to support ending cannabis prohibition. Join us in celebrating National Voter Registration Day next Tuesday by double-checking your status as a voter and encouraging your friends and family to do the same. Take a look at how we graded your members of Congress and bring that information with you to the polls on Election Day!

    State:

    California: Sixty percent of likely voters say they would vote for Proposition 64: the Adult Use of Marijuana Act according to the latest poll out of the Public Policy Institute of California (PPIC). Only 36 percent of voters said they are against the pending ballot initiative.

    A just-released California Field poll similarly finds that likely voters back Prop. 64 by a margin of 60 percent to 31 percent.

    Proposition 64 permits adults to legally grow (up to six plants) and possess personal use quantities of cannabis (up to one ounce of flower and/or up to eight grams of concentrate) while also licensing commercial cannabis production and retail sales. The measure prohibits localities from taking actions to infringe upon adults’ ability to possess and cultivate cannabis for non-commercial purposes. The initiative language specifies that it is not intended to “repeal, affect, restrict, or preempt … laws pertaining to the Compassionate Use Act of 1996.”

    The ballot measure is endorsed by the ACLU of California, the California Democratic Party, the California Medical Association, California Lt. Gov. Gavin Newsom, the California NAACP, the California League of Conservative Voters, Equality California, the Drug Policy Alliance, Students for Sensible Drug Policy, and NORML.

    pills_v_potMichigan: Governor Rick Snyder has signed a package of legislation into law regulating the retail sale of medical cannabis and cannabis-infused products. The measures are ordered to take immediate effect.

    The measures seek to clarify and expand various aspects of the state’s 2008 medical cannabis law. Specifically, the new law provides qualified patients for the first time with legal protections regarding the possession and use of non-smoked cannabis derived topical products and edibles, as well as cannabis-based extract products. The law also licenses and regulates facilities where state-qualified patients may legally obtain medical marijuana.

    Michigan was one of the only medical marijuana states in the country that had yet to regulate the dispensing of medicinal cannabis. About 210,000 residents are now registered in the state’s medical program.

    Missouri: Voters will not have the opportunity this November to decide on a proposed statewide proposition to permit the physician-supervised use of marijuana.

    A Cole County Circuit Judge this week upheld a decision by St. Louis election officials to disqualify thousands of petition signatures because voters had mistakenly signed forms indicating that they resided in a county other than where they lived.

    The measure, sponsored by New Approach Missouri, sought to authorize qualified patients to possess, cultivate, and/or obtain cannabis through a licensed system of dispensaries. Polling indicated that over 60 percent of voters backed the proposal. On Thursday, Secretary of State Jason Kander called on lawmakers to move swiftly to enact similar legislation.

    Voters in Arkansas, Florida, Montana, and North Dakota will vote on medical use measures on Election Day. Voters in Arizona, California, Maine, Massachusetts, and Nevada will also vote this November on initiatives legalizing the adult use of marijuana. A summary of 2016 ballot measures and their status is online here.

    Legalize marijuanaNew Jersey: New legislation has been introduced for the 2016/2017 legislative session that seeks to regulate the adult use and retail sale of marijuana.

    Assembly Bill 4193 permits marijuana to be sold at convenience stores to adults aged 19 and older in unlimited amounts. The legislation also seeks to expunge the criminal records of past marijuana offenders. Says the bill’s sponsor, Assembly member Michael Patrick Carroll: “To me it’s just not a big deal. It’s already ubiquitous. Anybody who thinks this is somehow going to increase the availability of marijuana has never been 19. If that’s the case, then what’s the big deal about having it available at the local 7-Eleven?”

    Separate legislation to legalize adult marijuana possession, A 2068, is also pending before the legislature. #TakeAction

    Tennessee: Members of the Nashville Metro Council have given final approval to municipal legislation providing police the discretion to cite rather than arrest minor marijuana offenders.

    Council members voted 35 to 3 in favor of the new ordinance. It provides police the option of issuing $50 citations for those who possess up to a half-ounce of marijuana. Under state law, the possession of small amounts of cannabis is classified as a criminal misdemeanor, punishable by up to one year in jail and a criminal record.

    The legislation now awaits action from the city’s mayor, who has pledged to sign the bill into law. A similar measure is awaiting a final city council vote in Memphis, Tennessee.

    Washington D.C.: District Mayor Muriel Bowser announced this week that she will propose amending the city’s medical cannabis law so that qualified patients may obtain up to four ounces of cannabis per month. Under existing law, patients are limited to no more than two ounces per month. The Washington D.C. currently has about 4,000 registered medical marijuana patients.

    Looking for updated information on all of the pending statewide marijuana related ballot measures? Check out our 2016 Election page!

  • by Danielle Keane, NORML Political Director September 16, 2016

    In this week’s Legislative Round Up you’ll learn about a national call to action to renew federal legislation protecting hundreds of thousands of patients and providers. In other news, the marijuana movement received support from two leading national veterans groups and several important bills were signed into law at the state level. Keep reading for the latest news in marijuana law reform.

    Federal:

    take_actionA federal provision limiting the Justice Department from prosecuting state-authorized medical marijuana patients and providers is set to expire at the end of this month. The provision, known as the Rohrabacher-Farr Amendment, maintains that federal funds can not be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.” Please visit our #TakeAction Center to contact your federally elected officials and urge them to move quickly to reauthorize the Rohrabacher-Farr Amendment and to keep these important patient protections in place.

    In other news of national significance, members of the American Legion passed a resolution to promote research on marijuana’s potential use for treating post-traumatic stress disorder and traumatic brain injury. Additionally, the group called for marijuana to be removed from it’s current Schedule I classification within the Controlled Substances Act. A second veterans group, The American Veterans (AMVETS), also recently resolved that marijuana should be made available to veterans within the VA healthcare system in every state where it is legal.

    State:

    Delaware: Governor Jack Markell has signed legislation, SB 181, into law permitting designated caregivers to possess and administer non-smoked medical marijuana formulations (e.g. oils/extracts) to qualifying patients “in a school bus and on the ground or property of the preschool, or primary, or secondary school in which a minor qualifying patient is enrolled.”

    The measure takes immediate effect. To date, two other states — Colorado and New Jersey — impose similar legislation.

    Florida: Another local municipality, New Port Richey, has approved marijuana decriminalization legislation. In a 3-2 vote, the council approved an ordinance providing police the discretion to issue a $155 civil citation in lieu of making a criminal arrest in cases involving less than 20 grams of marijuana. The New Port Richey vote mimics those of nearby municipalities Orlando and Tampa, which passed similar ordinances earlier this year and a wave of South Florida municipalities that passed similar ordinances last year. Under state law, simple marijuana possession is a criminal misdemeanor, punishable by up to one year in prison and a $1,000 fine.

    thumbs_upMichigan: Lawmakers gave final approval this week to a package of bills, HB 4209/4210, HB 4827, SB 141, and SB 1014, to regulate the retail sale of medical cannabis and cannabis-infused products. The legislation licenses and regulates above-ground, safe access facilities where state-qualified patients may legally obtain medical marijuana, provides qualified patients for the first time with legal protections for their possession and use of non-smoked cannabis derived topicals and edibles, as well as cannabis-based extract products, and establishes regulations tracking the production and sale of medical marijuana products. The measures, which lawmakers had debated for the past two years, now await action by the Governor. #TakeAction

    New Jersey: On September 14th, Governor Chris Christie signed legislation, A 457, into law that adds PTSD to the list of qualifying conditions eligible for medical marijuana therapy. More than a dozen states permit medical marijuana access for PTSD treatment. A retrospective review of PTSD patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction CAPS (Clinician Administered Posttraumatic Scale) symptom scores following cannabis therapy.

    The new law took immediate effect.

    Tennessee: Last week the Nashville Metro Council advanced legislation providing police the option to cite rather than arrest minor marijuana offenders. Those cited would face only a $50 fine (or ten hours of community service.) Under state law, such offenses are punishable by up to one-year in prison. A final vote on the ordinance is scheduled for September 20. If you live in Nashville, consider contacting your member of the Metro Council and voicing your support for this common sense reform.

  • by Keith Stroup, NORML Legal Counsel September 12, 2016

    Logo-1-R4One of the next frontiers in the political battles for marijuana smokers is the need to provide venues where marijuana smokers can socialize with other marijuana smokers in a marijuana-friendly lounge. Under current laws in Washington, Colorado, Oregon, and the District of Columbia, it is perfectly legal for smokers to possess specified amounts of marijuana, but they are only legally allowed to exercise their newly won freedom in their home or as a guest in someone else’s home.

    Holland-style coffee shops, or marijuana lounges were not legalized by those early voter initiatives.

    This is particularly important to the many tourists who visit those states, as most will have nowhere legal to smoke their legal cannabis. Most hotels don’t allow cannabis consumption, and public marijuana smoking is outlawed – meaning there are a lot of people with no place to go to enjoy their legal bud.

    That is about to change.

    Can you imagine for a moment what the alcohol scene would look like today if alcohol drinkers were precluded from drinking at bars, and only allowed to drink alcohol in a private home? That would largely eliminate the lively night life scene in every city in America, and it would surely result in the rise of speakeasies, clandestine illegal bars similar to those that arose in several states before the end of alcohol prohibition.

    It is equally absurd to suggest that the tens of millions of Americans who smoke marijuana, once it is legalized, will have to limit their marijuana smoking to private homes. There is absolutely no policy justification for this limitation, and smokers will always find a way around it.

    The choice: Regulate smoking lounges or smoke-easies will proliferate.

    It is the nature of a free market. If the government does not license and regulate the market, those willing to operate in the “grey zone” will fill the void and develop venues where marijuana smokers can socialize with other marijuana smokers. There are currently smoke-easies operating in many cities, in states that have legalized marijuana. But because these are not technically legal, the state and local jurisdiction does not receive the tax revenue, nor can they regulate the qualify or safety of the product. When marijuana is being sold illegally, the products are not tested in a certified laboratory for molds and pesticides, nor is there any way to assure the labeling is accurate as to the strength of the drug.
    Marijuana smoking is a social activity better enjoyed with friends, so the only real question is whether these marijuana-friendly clubs will continue to be clandestine, or whether they will be licensed and regulated and above ground.

    A licensed and regulated system, with age controls, is far preferable to grey market “smoke-easies.”

    This push for smoking lounges is currently being principally fought in Alaska, within the state agency developing the rules for legal marijuana in that state; and in Denver, where two versions for social marijuana use were competing for the November ballot.

    The situation in Alaska.

    First, let’s look at the Alaska situation. Last November, the Alaska Marijuana Control Board issued draft regulations to define when and where “on-site consumption” would be permitted. The proposed regulations have for several months been open for public comment and were expected to be approved this past week, but that vote has now been delayed until October.

    While the proposed regulations are still tentative, marijuana cafes would be permitted in Alaska only in conjunction with an existing marijuana retail store, on the same premises, either indoor or outdoor, but with a separate entrance and separate serving area. A separate license would be required for on-site consumption.

    Customers could purchase small amounts of marijuana (1 gram of marijuana, edibles with up to 10 milligrams of THC, or .25 grams of marijuana concentrates) to consume on-site and would not be permitted to bring their own marijuana to smoke on-site. Strangely, an early version of the regulations said the legal smokers would be required to leave any unfinished marijuana behind to be destroyed, although this was met with some strong opposition, and has now been deleted. Customers would now be permitted to reseal their unused marijuana and take it with them. Also, marijuana “happy hours” would not be permitted, although marijuana lounges would be permitted to sell food and non-alcohol beverages.

    It appears that Alaska may well become the first state to license marijuana lounges, some of which could be up and running within a few months. It is incredibly important for the legalization movement nationwide for a couple of states to move forward to experiment with new marijuana-friendly venues, to serve as a living experiment, which other states can evaluate when they are facing these same issues down the road. If the initial experience with marijuana lounges is generally successful, and if the lounges do not present any unintended consequences in the communities they serve, other states that legalize marijuana will want to incorporate this specific wrinkle in their policy.

    Alaska is set to be our first social use club demonstration.

    The Denver, Colorado experience.

    Denver presents a different situation, as there the effort to legalize social use venues is being fought by way of a city-wide voter initiative. In fact, there were two competing marijuana lounge initiatives being circulated this fall.

    One (proposed by Denver NORML and the Committee for the Responsible Use Initiative in Denver) that would have established licenses for marijuana only (no alcohol) social use clubs and for special events, was a grass-roots undertaking, and despite a valiant effort, the sponsors fell short of the required number of registered voters (5,000), so that proposal will not be on the ballot this fall.

    Jordan Person, the chief advocate, said she was surprised by the number of rejected signatures for the group’s private clubs initiative, adding that it underlined the need for more voter registration drives.

    “You know, we’re not going to stop,” she told me, arguing that private clubs are the better solution to the need for places where people, including tourists, can consume marijuana together.

    The second proposal for social use clubs was proposed at the last minute, offered as a competing initiative by the Cannabis Consumption Committee, an industry group that had qualified a similar measure for the ballot in 2015 before pulling it from the ballot at the last minute, in a failed attempt to work with the City Council. Over a thirty-day period, with industry funding, the group managed to collect 10,800 signatures to qualify.

    (One would naturally ask why there would be competing social use voter initiatives; were they so different that a reasonable compromise could not have been reached, offering a united social use initiative? The answer, of course, is that individual personalities and egos naturally get involved, and in this case, despite an extraordinary effort by Denver NORML attorney Judd Golden and Executive Director Jordan Person to reach an accord with the industry group, in the end, a compromise was not possible. So we were left with two competing social use initiatives being circulated for signatures in Denver.)

    The initiative that did qualify for the ballot would permit certain bars and restaurants to obtain a social use license in which marijuana edibles and vaporizers could be used, but no marijuana could be smoked (because of Colorado’s strong indoor clean air act), and approval would have to be obtained from neighborhood groups and business improvement districts before any such license could be awarded. This requirement may well prove a somewhat challenging proposition in today’s world of NIMBY (not in my backyard), as neighborhood groups may be fearful of the social consequences of allowing marijuana products to be consumed in conjunction with alcohol.

    The proposal would establish a four-year pilot program, requiring the city to study the measure’s effectiveness. By the end of 2020, the City Council could allow it to expire, make it permanent or tweak its provisions.

    So we are left in Denver with a proposal that we should all support, as it moves us a little closer to the goal of being allowed to smoke marijuana with friends in a social setting, outside a private home. But it remains to be seen how many neighborhood associations are likely to allow the issuance of licenses. Nonetheless, it does recognize the need for responsible marijuana smokers to have a place to congregate where they can socialize with other smokers. And we should all do what we can to get the Denver social use initiative approved by the voters in November.

    It’s certainly not a perfect social use initiative, assuming the goal remains to treat marijuana like alcohol, but as this is new territory for the legalization movement, we should use this proposal to try to demonstrate that social use clubs are a viable alternative to the current policy of limiting marijuana smoking to a private home.

    The most current polling suggests the proposal is favored by a clear majority (56 percent) of voters in Denver.

    Laboratories of democracy.

    As former U.S. Supreme Court Justice Louis Brandeis famously said, “a state may, if its citizens choose, serve as a laboratory and try novel social and economic experiments without risk to the rest of the country.” The city of Denver and the state of Alaska are exercising that important role as we move forward with new and improved versions of legalization. What we learn from these initial experiments with marijuana social clubs will inform subsequent cities and states in the coming years.

  • by Paul Armentano, NORML Deputy Director September 7, 2016

    AUMAMore than seven in ten Californians say that they favor voting ‘yes’ on Proposition 64: the Adult Use of Marijuana Act, according to polling data compiled by the CALSPEAKS Opinion Research Center at Sacramento State.

    Seventy-one percent of respondents say that they are leaning toward voting in favor of the statewide initiative. Public support is strongest among those between the ages of 18 and 34 (84 percent) Latinos (81 percent), Democrats (80 percent), those between the ages of 50 and 64 (74 percent), and Independents (72 percent).

    The poll’s margin of error is +/- four percentage points.

    Polling data compiled last month by by the Institute of Government Studies at the University of California, Berkeley reported that 64 percent of California voters believe, “Marijuana should be legal for adults to purchase and use recreationally, with government regulations similar to the regulation of alcohol.”

    Proposition 64 permits adults to legally grow (up to six plants) and possess personal use quantities of cannabis (up to one ounce of flower and/or up to eight grams of concentrate) while also licensing commercial cannabis production and retail sales. The measure prohibits localities from taking actions to infringe upon adults’ ability to possess and cultivate cannabis for non-commercial purposes. The initiative language specifies that it is not intended to “repeal, affect, restrict, or preempt … laws pertaining to the Compassionate Use Act of 1996.” Proposition 64 is endorsed by the ACLU of California, the California Democratic Party, the California Medical Association, California Lt. Gov. Gavin Newsom, the California NAACP, the Drug Policy Alliance, Students for Sensible Drug Policy, and NORML.

    Similar adult use measures will also appear on the ballot this November in Arizona, Maine, Massachusetts, and Nevada.

    A summary of 2016 statewide ballot measures and their status is online here.

Page 1 of 3812345...102030...Last »